Stock exchange intimation

Stock Exchange Intimation

Filter:

19 May 2026 – In furtherance to the intimation dated May 13, 2026, w.r.t the resignation of SMP, please find enclosed the resignation document
19 May 2026 – Intimation of Transcript of Earnings call dated May 13, 2026
16 May 2026 – Government of Karnataka has accorded in-principle approval for the application submitted by the Company for Unit-II expansion project under the Karnataka Industrial Policy (KIP) 2025-30, towards incentives and concessions
14 May 2026 – Intimation about publication of newspaper advertisement – Extract of Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026
13 May 2026 – Intimation of Audio Recording of Earnings call pertaining to the Audited Financial Results for the quarter and financial year ended March 31, 2026
13 May 2026 – Intimation of the outcome of the Board meeting dated May 13, 2026 for approval of the Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026
13 May 2026 – Intimation for: Resignation of Senior Management Personnel effective from May 13, 2026
13 May 2026 – Intimation for: Allotment of shares pursuant to “OneSource ESOP Scheme 2021”
13 May 2026 – Intimation for: Appointment of BSR & Co.LLP Chartered Accountants as the Statutory Auditors of the Company
13 May 2026 – Intimation for: Update On Composite Scheme of Amalgamation
13 May 2026 – Intimation regarding: Investor Presentation & Press Release: OneSource announces FY 2026 results with strong Q4 performance; reaffirms FY28 guidance.
07 May 2026 – Intimation regarding Q4FY26 earnings call
07 May 2026 – Intimation for Board Meeting
04 May 2026 – OneSource Supports Second Generic Semaglutide Approval in Canada- Enables commercialisation for the first two entrants in the world’s second-largest semaglutide market
29 Apr 2026 – OneSource’s Partner Dr. Reddy’s Laboratories receives Health Canada Approval for Generic Semaglutide Injection